Gilead’s earnings and revenues beat in the third quarter

Investing.com – Gilead reported third-quarter financial results on Thursday that topped analyst expectations, with revenue topping forecasts.

The company reported earnings per share of $1.84 on revenue of $5.6 billion. Analysts polled by Investing.com forecast EPS of $1.62 on revenue of $5.37 billion. This compares to EPS of $2.27 on revenue of $6.51 billion in the same period a year earlier. The company reported EPS of $1.91 on revenue of $5.65 billion in the year-ago quarter.

Gilead shares gained 1.43% to trade at $69.60 following the report.

Gilead shares are down 4.95% for the year, underperforming the Nasdaq which is up 5.49% year to date.

Gilead tracks performance of other major healthcare sectors this month

On October 16, J&J (NYSE:JNJ) reported third-quarter EPS of $2.05 on revenue of $20.35 billion, compared to the consensus estimate of EPS of $2.03 on revenue of $20.04 billion.

Novartis ADR earnings exceeded analyst expectations on October 18, with third-quarter earnings per share of $1.32 on revenue of $12.78 billion. Analysts at Investing.com expected earnings of $1.31 per share on revenue of $12.98 billion

Stay up to date on all upcoming earnings reports by visiting the earnings calendar on Investing.com

FANG’s $200 billion market capitalization went up in smoke in two sessions

Uber goes to court to defend its business model in the context of workers’ rights in the UK

US plans more tariffs on China if Trump-Xi meeting fails: Bloomberg